Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST tool validation in niacin and aspirin treated dyslipidemia
NCT00630877Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2008
- Primary completion
- Jun 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of niacin, aspirin in dyslipidemia, sponsored by Abbott Laboratories. Started Feb 2008; status: completed.
02
Drugs
niacinaspirin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00630877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630877.